Insider · CIK 0001287920

BOUDREAUX GAIL

Reports to the SEC for 7 companies · INDIANAPOLIS, IN

sec.gov

Transactions

Companies

Filings

CIK

0001287920

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-17	ELVElevance Health, Inc.P Purchase	Director, President and CEO	PPurchase	+2,045 sh	$368.25	+$753K	171,976
2026-07-17	ELVElevance Health, Inc.P Purchase	Director, President and CEO	PPurchase	+680 sh	$366.41	+$249K	169,931
2026-03-11	TGTTARGET CORPA Award	Director	AAward	+2,682 sh	—	—	12,192
2026-03-03	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−1,736 sh	$284.03	−$493K	169,251
2026-03-02	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−6,713 sh	$294.07	−$1.97M	144,307
2026-03-02	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+63.8K sh	—	—	63,818
2026-03-02	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+16.2K sh	—	—	160,460
2026-03-02	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+10.5K sh	—	—	170,987
2025-07-18	ELVElevance Health, Inc.P Purchase	Director, President and CEO	PPurchase	+1,050 sh	$287.96	+$302K	151,020
2025-07-18	ELVElevance Health, Inc.P Purchase	Director, President and CEO	PPurchase	+5,116 sh	$287.12	+$1.47M	149,970
2025-07-18	ELVElevance Health, Inc.P Purchase	Director, President and CEO	PPurchase	+2,334 sh	$286.07	+$668K	144,854
2025-03-12	TGTTARGET CORPA Award	Director	AAward	+2,946 sh	—	—	9,067
2025-03-03	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−10.4K sh	$395.50	−$4.11M	116,313
2025-03-03	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+40.4K sh	—	—	40,429
2025-03-03	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+10.6K sh	—	—	126,933
2025-03-03	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+15.6K sh	—	—	142,520
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−1,100 sh	$498.50	−$548K	159,609
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−1,000 sh	$503.67	−$504K	128,959
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−2,250 sh	$502.23	−$1.13M	129,959
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−6,621 sh	$501.40	−$3.32M	132,209
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−20.8K sh	$500.36	−$10.4M	138,830
2024-07-22	ELVElevance Health, Inc.S Sale	Director, President and CEO	SSale	−2,250 sh	$504.27	−$1.13M	126,709
2024-03-13	TGTTARGET CORPA Award	Director	AAward	+1,873 sh	—	—	5,918
2024-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+8,415 sh	—	—	126,192
2024-03-01	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−19.3K sh	$499.11	−$9.61M	117,777
2024-03-01	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+32.5K sh	—	—	32,480
2024-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+34.5K sh	—	—	160,709
2023-03-08	TGTTARGET CORPA Award	Director	AAward	+1,902 sh	—	—	3,896
2023-03-02	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−17.6K sh	$468.78	−$8.26M	135,863
2023-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+35.9K sh	—	—	153,477
2023-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+8,422 sh	—	—	117,602
2023-03-01	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−2,471 sh	$469.03	−$1.16M	109,180
2023-03-01	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+32.4K sh	—	—	32,380
2022-11-04	ELVElevance Health, Inc.G Gift	Director, President and CEO	GGift	−10K sh	—	—	111,415
2022-03-09	TGTTARGET CORPA Award	Director	AAward	+1,432 sh	—	—	1,949
2022-03-02	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−1,645 sh	$463.49	−$762K	120,639
2022-03-01	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+32.7K sh	—	—	32,682
2022-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+28.3K sh	—	—	122,284
2022-03-01	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−15.4K sh	$451.50	−$6.93M	85,786
2022-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+8,195 sh	—	—	93,981
2021-09-23	TGTTARGET CORPA Award	Director	AAward	+514 sh	—	—	514
2021-03-31	ZBHZIMMER BIOMET HOLDINGS, INC. · Phantom Stock UnitsA Award	Director	AAward	+169.785 sh	—	—	11,743.19
2021-03-02	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−1,644 sh	$311.66	−$512K	100,300
2021-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+73.2K sh	—	—	101,944
2021-03-01	ELVElevance Health, Inc.A Award	Director, President and CEO	AAward	+10.6K sh	—	—	28,704
2021-03-01	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−35.6K sh	$311.48	−$11.1M	18,109
2021-03-01	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+43.5K sh	—	—	43,501
2020-12-31	ZBHZIMMER BIOMET HOLDINGS, INC. · Phantom Stock UnitsA Award	Director	AAward	+179.891 sh	—	—	11,555.713
2020-12-01	ELVElevance Health, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−14.8K sh	$313.90	−$4.63M	53,594
2020-09-30	ZBHZIMMER BIOMET HOLDINGS, INC. · Phantom Stock UnitsA Award	Director	AAward	+202.563 sh	—	—	11,355.245

Recent filings

Accepted (ET)
Jul 174
BOUDREAUX GAIL0001287920-26-000006
SEC(opens sec.gov)
Mar 134
BOUDREAUX GAIL0001287920-26-000004
SEC(opens sec.gov)
Mar 44
BOUDREAUX GAIL0001287920-26-000002
SEC(opens sec.gov)
Jul 184
BOUDREAUX GAIL0001287920-25-000005
SEC(opens sec.gov)
Mar 144
BOUDREAUX GAIL0000027419-25-000059
SEC(opens sec.gov)
Mar 54
BOUDREAUX GAIL0001156039-25-000022
SEC(opens sec.gov)
Jul 234
BOUDREAUX GAIL0001156039-24-000109
SEC(opens sec.gov)

Companies

Address

220 VIRGINIA AVENUE

INDIANAPOLIS, IN, 46204